Steroid Receptor Signallings as Targets for Resveratrol Actions in Breast and Prostate Cancer
Extensive research over the past 25 years in hormone-dependent cancers, such as breast cancer and prostate cancer, has identified the molecular mechanisms driven by steroid receptors, elucidating the interplay between genomic and non-genomic steroid receptors mechanism of action. Altogether, these m...
Main Authors: | Francesca De Amicis, Adele Chimento, Francesca Ida Montalto, Ivan Casaburi, Rosa Sirianni, Vincenzo Pezzi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/20/5/1087 |
Similar Items
-
Progress to Improve Oral Bioavailability and Beneficial Effects of Resveratrol
by: Adele Chimento, et al.
Published: (2019-03-01) -
Androgen receptor and prostate cancer
by: Karen E. Livermore, et al.
Published: (2016-06-01) -
Pathogenesis of prostate cancer and hormone refractory prostate cancer
by: J S Girling, et al.
Published: (2007-01-01) -
Therapies Targeted to Androgen Receptor Signaling Axis in Prostate Cancer: Progress, Challenges, and Hope
by: Sirin Saranyutanon, et al.
Published: (2019-12-01) -
Androgen Receptor Roles in Benign and Malignant Prostate Disease
Published: (2011-06-01)